Breaking Down Ningbo Yongxin Optics Co.,Ltd Financial Health: Key Insights for Investors

Ningbo Yongxin Optics (603297.SS) presents a mixed but compelling snapshot for investors: 2024 revenue reached CNY 891.76 million (up 4.41% from CNY 854.13 million) with TTM revenue as of Sep 2025 at CNY 915.11 million (+2.35% YoY), while market confidence is reflected in a market cap of CNY 10.69 billion as of Nov 18, 2025 (up 27.77% YoY); profitability shows strain with 2024 net income of CNY 208.58 million (down 11.37%) and a net profit margin slipping to 23.4% from 27.6% in 2023, even as EBITDA TTM (Mar 31, 2025) was CNY 274.44 million and ROE TTM (Mar 31, 2025) stood at 11.31%; balance sheet strength is evident in cash/short-term investments of CNY 1.06 billion and total assets of CNY 2.26 billion (June 30, 2025) against modest total debt of CNY 303.92 million, yet valuation metrics are rich-trailing P/E 42.39, forward P/E 28.07, P/S 10.31 and EV/EBITDA 43.36 (Jul 5, 2025)-while growth levers include ties to leading LiDAR firms, targeted medical optics revenue objectives, and projected net profit progression to CNY 394 million by 2026; delve into the full breakdown to weigh liquidity, leverage, margins, valuation premiums and the key risks and opportunities that investors must consider.

Ningbo Yongxin Optics Co.,Ltd (603297.SS) - Revenue Analysis

• 2024 revenue: CNY 891.76 million, up 4.41% from CNY 854.13 million in 2023.
• TTM revenue (as of Sep 2025): CNY 915.11 million, +2.35% YoY versus the prior twelve-month period.
• Q2 2025 quarterly revenue: CNY 221.27 million, +4.16% YoY for the quarter.
• Gross profit margin (FY 2024): 37.73% (down from 41.70% in 2022), signaling tightening cost or mix pressures.
• Revenue per employee (2024): ~CNY 677,980, indicating relatively efficient human capital utilization.
• Market capitalization (Nov 18, 2025): CNY 10.69 billion, a 27.77% increase year-over-year, reflecting market re-rating alongside revenue growth.

Ningbo Yongxin Optics Co.,Ltd (603297.SS) Profitability Metrics

• Net income declined to CNY 208.58 mln in 2024, down 11.37% from CNY 235.95 mln in 2023.
• Net profit margin compressed to 23.4% in 2024 from 27.6% a year earlier, signaling margin pressure.
• Operating margin remained robust at 20.79% in 2024, only slightly below 22.5% in 2023, indicating continued operational efficiency.
• EPS fell to CNY 1.87 in 2024, a 12.6% decline from CNY 2.14 in 2023-mirroring the net income drop.
• TTM ROE of 11.31% (to Mar 31, 2025) suggests the company is generating a reasonable return on shareholders' equity despite year-over-year earnings pressure.
• TTM EBITDA of CNY 274.44 mln indicates strong operational cash-flow generation, supporting debt service and reinvestment capacity.

• Interpretation: margins and EPS show a modest deterioration in 2024, but high operating margin and healthy EBITDA point to resilient core operations.
• Key monitoring points for investors: margin recovery, trend in net income, ROE trajectory, and how EBITDA converts to free cash flow.

For the company's guiding principles and direction linked to these financial outcomes, see: Mission Statement, Vision, & Core Values (2026) of Ningbo Yongxin Optics Co.,Ltd.

Ningbo Yongxin Optics Co.,Ltd (603297.SS) - Debt vs. Equity Structure

Ningbo Yongxin Optics presents a capital structure characterized by a strong equity base and relatively low leverage. Key balance-sheet and market valuation metrics (mid‑2025 to late‑2025) highlight how the company finances operations and how the market prices its equity and enterprise value.

• Total assets (30 Jun 2025): CNY 2.26 billion
• Total liabilities / total debt (30 Jun 2025): CNY 303.92 million
• Total equity (30 Jun 2025): CNY 1.95 billion
• Debt-to-equity (30 Jun 2025): approximately 9.34%
• Price-to-book (P/B) (5 Jul 2025): 4.63
• Enterprise value-to-revenue (EV/Revenue) (5 Jul 2025): 9.74
• Market capitalization (18 Nov 2025): CNY 10.69 billion (YoY +27.77%)

Implications for investors:

• Low debt load (CNY 303.92M) vs. equity (CNY 1.95B) implies financial flexibility and lower default risk.
• Debt-to-equity ~9.34% signals a conservative capital structure, limiting interest burden and refinancing risk.
• High P/B (4.63) and EV/Revenue (9.74) indicate the market is pricing in premium growth expectations or high profitability relative to book and sales.
• Market cap appreciation (+27.77% YoY to CNY 10.69B) suggests investor confidence; monitor valuation multiples versus peers to assess whether premium is justified.

Further context on corporate strategy and long-term positioning can be found here: Mission Statement, Vision, & Core Values (2026) of Ningbo Yongxin Optics Co.,Ltd.

Ningbo Yongxin Optics Co.,Ltd (603297.SS) - Liquidity and Solvency

Ningbo Yongxin Optics presents a solid short-term liquidity position and conservative leverage as of June 30, 2025, underpinned by meaningful cash holdings, asset growth and modest liabilities. Key headline figures and their year‑over‑year movements are summarized below.

• Cash weight: Cash & short‑term investments of CNY 1.06 billion represent approximately 46.9% of total assets, indicating a high proportion of liquid assets available for operations, capex or opportunistic investments.
• Leverage profile: Total liabilities of CNY 303.92 million imply a debt-to-assets ratio near 13.4%, signalling conservative leverage and lower solvency risk compared with highly leveraged peers.
• Profitability supports solvency: A net profit margin of 23.79% provides strong internal cash generation, reinforcing the company's ability to service liabilities and fund growth.

Detailed implications for stakeholders:

• Short‑term resilience - Positive net change in cash this quarter (CNY 55.29 million) combined with +15.74% YoY cash growth reduces refinancing and liquidity risk.
• Balance sheet flexibility - With assets growing 7.12% and liabilities up only 3.41% YoY, the company can prioritize strategic investments without materially increasing leverage.
• Operational efficiency - ROA of 4.03% alongside a near 24% net margin suggests profitable operations and effective conversion of asset base into earnings.

For broader context on the company's structure and business model, see: Ningbo Yongxin Optics Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Ningbo Yongxin Optics Co.,Ltd (603297.SS) - Valuation Analysis

• Trailing P/E (as of July 5, 2025): 42.39 - implies the market paid CNY 42.39 for each CNY 1 of trailing earnings, signaling high growth expectations or limited near-term earnings visibility.
• Forward P/E (as of July 5, 2025): 28.07 - lower than trailing P/E, suggesting analysts expect earnings to improve over the next 12 months.
• P/S (TTM, as of July 5, 2025): 10.31 - the market values the company at over ten times its annual sales, a premium relative to many industrial peers.
• EV/EBITDA (as of July 5, 2025): 43.36 - a high multiple indicating the enterprise value considerably exceeds operating cash-generation on an EBITDA basis.
• P/B (as of July 5, 2025): 4.63 - equity trades at nearly 4.6x book value, consistent with a premium valuation for asset-light, high-margin expectations.
• Total debt (as of June 30, 2025): CNY 303.92 million - modest absolute debt, reflecting conservative leverage relative to market cap.

• Growth expectations: The significant gap between trailing P/E (42.39) and forward P/E (28.07) points to projected margin or revenue improvement baked into forward estimates.
• Revenue premium: A P/S of 10.31 shows investors assign strong revenue-based value, common for niche manufacturers with differentiated technology or high-margin products.
• High EV/EBITDA: At 43.36, this multiple signals that enterprise value is high relative to cash-operating profits - investors may be anticipating rapid EBITDA expansion or viewing current EBITDA as suppressed by temporary factors.
• Conservative leverage: Total debt of CNY 303.92 million versus market cap of CNY 10.69 billion (as of Nov 18, 2025) suggests financial flexibility and limited refinancing risk at present.
• Equity premium: P/B of 4.63 underscores market willingness to pay above net asset value for intangible assets, brand, or expected ROE outperformance.

Ningbo Yongxin Optics Co.,Ltd (603297.SS) - Risk Factors

Ningbo Yongxin Optics faces a mix of operational strengths and financial headwinds that investors should weigh carefully. Key hard figures highlight areas of concern alongside pockets of resilience.

• Net income decline: fiscal 2024 net income down 11.37% vs. 2023, signaling pressure on bottom-line growth.
• Net profit margin contraction: 23.4% in 2024 vs. 27.6% in 2023 - lower profitability per unit revenue.
• EPS deterioration: fiscal 2024 EPS CNY 1.87, a 12.6% drop from CNY 2.14 in 2023, reducing shareholder returns.
• Operating margin slightly lower: 20.79% in 2024 vs. 22.5% in 2023, indicating relatively stable but declining operational efficiency.
• ROE remains respectable: trailing twelve months (TTM) ending 31-Mar-2025 ROE at 11.31%, showing continued equity utilization.
• Strong EBITDA: TTM ending 31-Mar-2025 EBITDA CNY 274.44 million - positive indicator of operational cash generation.

Primary risk vectors for investors:

• Profitability compression - declining net margin and EPS may suggest pricing pressure, higher input costs, or mix shifts.
• Revenue sensitivity - if top-line growth slows, existing margin declines will more quickly erode net income.
• Concentration and customer risk - dependence on key customers or segments could magnify downturns.
• Supply chain & input-cost volatility - raw material or logistics cost spikes can further reduce margins despite solid EBITDA.
• Currency and macro exposure - FX moves and slower end-market demand (e.g., electronics, automotive optics) pose cyclical risks.
• Capital allocation & balance-sheet risk - moderate ROE and solid EBITDA help, but leverage, capex needs, or dividend policy shifts could affect equity returns.
• Competitive and technological risk - rapid tech changes in optics/manufacturing require ongoing R&D; failure to innovate may compress future margins.
• Regulatory/market access - evolving trade, export controls, or certification requirements could raise costs or restrict markets.

For context on the company's broader background and business model, see: Ningbo Yongxin Optics Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Ningbo Yongxin Optics Co.,Ltd (603297.SS) - Growth Opportunities

Ningbo Yongxin Optics has positioned itself to capture multiple high-growth end markets through strategic partnerships, targeted incentives, and product diversification. Key catalysts include deep cooperation with leading LiDAR suppliers, a focused equity incentive tied to medical optics revenue, incremental exposure to lithography optics, and favorable national equipment renewal policies that support domestic adoption of high-end optical microscopes. Further expansion in LiDAR and medical optics components is explicitly called out by management as a roadmap to unlock additional revenue and margin expansion.

• Strategic partnerships: established OEM/technology relationships with Hesai, Tuodaton, and Valeo to serve the LiDAR optics market, positioning the company for volume growth as autonomous driving and industrial sensing scale.
• Medical optics push: equity incentive plan requires medical optics business revenue ≥ CNY 90 million in 2024, signaling both management commitment and measurable short-term targets.
• Lithography optics runway: currently a small product base in lithography-related equipment with explicit plans to increase share as domestic lithography demand grows.
• Policy tailwinds: expected to benefit from national equipment renewal initiatives that prioritize domestic high-end optical microscope adoption.
• Product-led expansion: management targets additional growth via optical components for LiDAR and medical optics to broaden addressable market and diversify end-market cyclicality.

Revenue and profit growth implied by the 2024-2026 forecasts reflect both organic demand increases and higher-margin contributions from targeted segments (medical optics, LiDAR optics, lithography). The company's cooperation with Hesai, Tuodaton, and Valeo provides near-term order visibility for LiDAR optics, while the equity incentive plan creates alignment to accelerate medical optics commercialization and revenue capture.

• Near-term growth vectors: LiDAR optics volume scaling via partner pipelines; medical optics reaching the CNY 90m milestone in 2024; incremental lithography optics wins as domestic equipment adoption rises.
• Medium-term margin upside: mix shift to higher-margin medical and precision optics; potential pricing/leverage improvements as volume ramps.
• Execution risks to monitor: timing of partner projects, conversion of medical R&D to stable revenue, and competitive dynamics in domestic lithography and LiDAR supply chains.

For deeper context on corporate history, ownership and business model details see: Ningbo Yongxin Optics Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money